The Qualified Person for Pharmacovigilance (QPPV) is a key role in the
field of drug safety and regulatory compliance. The QPPV is responsible
for overseeing the pharmacovigilance system of a pharmaceutical company or
a marketing authorization holder, ensuring that all adverse events and
safety issues related to their products are effectively monitored,
evaluated, reported and managed in compliance with relevant regulations.
The QPPV acts as the main point of contact between the company and
regulatory authorities, providing oversight and guidance to their team of
pharmacovigilance professionals. They are responsible for ensuring the
safety of the company’s products throughout their lifecycle, from clinical
trials to post-marketing surveillance.
The QPPV must have a thorough understanding of the company’s products and
the regulations governing their use, as well as the ability to effectively
communicate safety information to both internal and external stakeholders.
They must also maintain a continuous monitoring of safety data and
emerging safety concerns, and ensure that appropriate actions are taken in
a timely manner to protect patient safety.
In China the similar role is named Responsible Person for
Pharmacovigilance (RPPV). The main scope, responsibility, and regulatory
requirement of RPPV is illustrated in China GVP.
See also Comparison of EU-QPPV and China RPPV Section for more detailed
China RPPV requirement.
Should you have any queries or seeking for consultation, please contact
us via online chat or email.
Submit downloader info
Provisions for Administration of Drug-related Associated Review & Approval for APIs, Excipients. and Packaging Materials (2020 Draft for Comments)
Announcement on Issues Concerning the Further Improvement of Drug-related Associated Review & Approval and Supervision (2019 No.56)
Announcement for Adjusting Evaluation and Approval for APls, Excipients and Packaging Materials (2017 No.146)